Systematic investigation and comparison of US FDA-approved immunosuppressive drugs FK506, cyclosporine and rapamycin for neuromuscular regeneration following chronic nerve compression injury

Regenerative Medicine,Volume 16, Issue 11, Page 989-1003, November 2021.
Source: Future Medicine: Regenerative Medicine - Category: Genetics & Stem Cells Authors: Source Type: research
More News: Brain | Genetics | Neurology | Restasis